Reply

Katy Bell¹, Jenny Doust², Kevin McGeechan¹, Andrea R Horvath³, Alexandra Barratt¹, Andrew Hayen⁴, Christopher Semsarian^{5

6

7}, Les Irwig¹

Affiliations

¹ Wiser Healthcare, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales.
² Institute for Evidence-Based Healthcare (IEBH), Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland.
³ Department of Clinical Chemistry and Endocrinology, New South Wales Health Pathology.
⁴ Australian Centre for Public and Population Health Research, University of Technology Sydney (UTS).
⁵ Agnes Ginges Centre for Molecular Cardiology at Centenary Institute.
⁶ Sydney Medical School, Faculty of Medicine and Health, The University of Sydney.
⁷ Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Comment

Katy Bell et al. J Hypertens. 2021.

. 2021 May 1;39(5):1045-1046.

doi: 10.1097/HJH.0000000000002781.

Katy Bell¹, Jenny Doust², Kevin McGeechan¹, Andrea R Horvath³, Alexandra Barratt¹, Andrew Hayen⁴, Christopher Semsarian^{5

6

7}, Les Irwig¹

¹ Wiser Healthcare, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales.
² Institute for Evidence-Based Healthcare (IEBH), Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland.
³ Department of Clinical Chemistry and Endocrinology, New South Wales Health Pathology.
⁴ Australian Centre for Public and Population Health Research, University of Technology Sydney (UTS).
⁵ Agnes Ginges Centre for Molecular Cardiology at Centenary Institute.
⁶ Sydney Medical School, Faculty of Medicine and Health, The University of Sydney.
⁷ Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

No abstract available

Comment on

The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines.
Bell K, Doust J, McGeechan K, Horvath AR, Barratt A, Hayen A, Semsarian C, Irwig L. Bell K, et al. J Hypertens. 2021 Feb 1;39(2):236-242. doi: 10.1097/HJH.0000000000002614. J Hypertens. 2021. PMID: 32773652 Free PMC article.
Understanding the impact of blood pressure guidelines and variability on hypertension diagnoses.
Visaria A, Raju P, Islam S, James J, Polamarasetti P. Visaria A, et al. J Hypertens. 2021 May 1;39(5):1044-1045. doi: 10.1097/HJH.0000000000002780. J Hypertens. 2021. PMID: 33824260 No abstract available.

1. Visaria A, Raju P, Islam S, James J, Polamarasetti P. Understanding the impact of blood pressure guidelines and variability on hypertension diagnoses. J Hypertens 2021; 39:1044–1045.
1. Bell K, Doust J, McGeechan K, Horvath AR, Barratt A, Hayen A, et al. The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines. J Hypertens 2021; 39:236–242.
1. Hamer M, Batty GD, Stamatakis E, Kivimaki M. Hypertension awareness and psychological distress. Hypertension 2010; 56:547–550.
1. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978; 299:741–744.
1. Macdonald LA, Sackett DL, Haynes RB, Taylor DW. Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis 1984; 37:933–942.